ADM, SGI partner on omega-3 DHA from algae

ADM, SGI partner on omega-3 DHA from algae

ADM and SGI have entered into a long-term agreement to commercialize omega-3 docosahexaenoic acid (DHA) from algae.

ARCHER Daniels Midland Co. (ADM) and Synthetic Genomics Inc. (SGI) announced that they have entered into a long-term agreement to commercialize omega-3 docosahexaenoic acid (DHA) from algae.

As part of the agreement, omega-3 DHA will be produced and marketed throughout the world by ADM's Foods & Wellness and Animal Nutrition groups.

DHA is typically found in fish and seafood products, but extracting DHA directly from algae grown in fermentation tanks yields a highly purified form of DHA, which can then be used as a dietary supplement for humans and in animal feed, the companies said.

"The ADM partnership with SGI will prove beneficial for both companies by capitalizing on the strengths of SGI's technologies and know-how while using ADM's significant scale and production capabilities to commercialize important products demanded by our customers," said Brent Fenton, president of ADM Animal Nutrition.

Volume:86 Issue:22

Hide comments

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish